QLT Liable For Unfair Trade In Visudyne Litigation

Law360, New York (November 7, 2006, 12:00 AM EST) -- A federal jury has found biopharmaceutical company QLT Inc. liable for unjust enrichment and unfair trade practices but not liable for trade secret misappropriation in a countersuit brought by the Massachusetts Ear and Eye Infirmary over eye treatment Visudyne.

The jury handed down the decision on Monday, awarding MEEI a royalty of 3.01% on the net sales of Visudyne. Net sales of the treatment from its launch in 2000 to the end of the past Sept. totaled $2.2 billion worldwide, according to QLT, but it is...
To view the full article, register now.